Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ATIIW SEC filings page.
This page shows Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
The data's dominant mechanic is financing flows supporting a balance sheet with negative equity and limited operating evidence.
FY2025 reported net income of$8.0M coexisted with operating cash flow of-$739K , so accounting profit was not reflected in cash generated by operations. Meanwhile, investing cash flow of-$231M was nearly offset by financing cash flow of$233M , indicating that the period's major cash movement was financed investment rather than internally generated operating cash.
Operating earnings quality is difficult to assess: the operating loss was
Solvency and liquidity point in different directions: assets of
Financial Health Signals
Archimedes Tech SPAC Partners II Co. Warrant does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
For every $1 of reported earnings, Archimedes Tech SPAC Partners II Co. Warrant used $0.09 of operating cash (-$739K OCF vs $8.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Archimedes Tech SPAC Partners II Co. Warrant reported -$136.8M in net income in Q2 2026. This represents a decrease of 5898.1% from the same quarter a year earlier. Against the prior quarter it is down 8121.6%.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Archimedes Tech SPAC Partners II Co. Warrant held $415K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
ATIIW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
ATIIW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $244.7M+3.3% | $243.2M+3.7% | $241.3M+56067.1% | $239.3M | $236.9M | $234.6M | $430K | N/A |
| Current Assets | $515K-72.9% | $1.2M-39.7% | $1.5M | $1.7M | $1.9M | $2.0M | $0 | N/A |
| Cash & Equivalents | $415K-76.5% | $1.1M-42.2% | $1.4M | $1.4M | $1.8M | $1.9M | $0 | N/A |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A |
| Total Liabilities | $390.7M+60.7% | $250.4M+4.0% | $248.0M+51214.3% | $245.7M | $243.2M | $240.7M | $483K | N/A |
| Current Liabilities | $138.5M+86952.6% | $309K+79.8% | $138K-71.6% | $129K | $159K | $172K | $483K | N/A |
| Non-Current Liabilities | $252.2M+3.8% | $250.1M+4.0% | $247.9M | $245.5M | $243.0M | $240.5M | $0 | N/A |
| Total Equity | -$146.1M-2234.5% | -$7.1M-16.6% | -$6.7M-12383.1% | -$6.4M-20743.4% | -$6.3M | -$6.1M | -$54K | -$31K |
| Retained Earnings | -$146.1M-2234.3% | -$7.1M-16.6% | -$6.7M-8418.6% | -$6.4M | -$6.3M | -$6.1M | -$79K | N/A |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ATIIW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
ATIIW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$6.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where Archimedes Tech SPAC Partners II Co. Warrant Ranks
Frequently Asked Questions
Is Archimedes Tech SPAC Partners II Co. Warrant profitable?
Yes, Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) reported a net income of $8.0M in fiscal year 2025.
What is Archimedes Tech SPAC Partners II Co. Warrant's operating cash flow?
Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) recorded an outflow of $739K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Archimedes Tech SPAC Partners II Co. Warrant's total assets?
Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) had $241.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Archimedes Tech SPAC Partners II Co. Warrant's current ratio?
Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) had a current ratio of 10.72 as of fiscal year 2025, which is generally considered healthy.
What is Archimedes Tech SPAC Partners II Co. Warrant's return on assets (ROA)?
Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) had a return on assets of 3.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Archimedes Tech SPAC Partners II Co. Warrant's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) held $1.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $739K over that year. Dividing the one by the other, the reported balance equals about 22 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Archimedes Tech SPAC Partners II Co. Warrant's debt-to-equity ratio negative or not reported?
Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) has negative shareholder equity of -$6.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are Archimedes Tech SPAC Partners II Co. Warrant's earnings high quality?
For every $1 of reported earnings, Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) used $0.09 of operating cash (-$739K OCF vs $8.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.